Pay in 4 interest-free payments of $5.04 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
Mov Disord Clin Pract
Authors : Xin Cui, Yueming Zhu, Lidan Zeng, Mengyuan Zhang, Amad Uddin, Theresa W Gillespie, Lauren E McCullough, Shaying Zhao, Mylin A Torres, Yong Wan Source : This study elucidates a molecular mechanism by which Retatrutide overcomes therapeutic resistance in obese triple-negative breast cancer (TNBC)
It must be handled in accordance with all applicable laws and regulations.
First, our model shows that a heparin molecule is sandwiched between the N domain of HGF I and the IPT1 domain of c-MET II, and acts as a glue to hold these two domains together
US$ 23.40
US$ 28.96
US$ 24.07
